Published in J Exp Med on November 01, 1996
Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells. J Exp Med (2003) 2.77
Receptor editing occurs frequently during normal B cell development. J Exp Med (1998) 2.01
A role for nuclear factor kappa B/rel transcription factors in the regulation of the recombinase activator genes. Immunity (2005) 1.81
Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies. J Exp Med (2013) 1.68
Polyspecificity of T cell and B cell receptor recognition. Semin Immunol (2007) 1.68
B-cell activation by membrane-bound antigens is facilitated by the interaction of VLA-4 with VCAM-1. EMBO J (2006) 1.43
Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells. J Exp Med (1997) 1.41
Harnessing CD4⁺ T cell responses in HIV vaccine development. Nat Med (2013) 1.39
Human autoantibody silencing by immunoglobulin light chains. J Exp Med (2004) 1.34
Self-antigen does not accelerate immature B cell apoptosis, but stimulates receptor editing as a consequence of developmental arrest. Proc Natl Acad Sci U S A (1997) 1.33
Capture of plasma membrane fragments from target cells by trogocytosis requires signaling in T cells but not in B cells. Blood (2008) 1.27
Immune tolerance negatively regulates B cells in knock-in mice expressing broadly neutralizing HIV antibody 4E10. J Immunol (2013) 1.14
Rearrangement of mouse immunoglobulin kappa deleting element recombining sequence promotes immune tolerance and lambda B cell production. Immunity (2008) 1.14
Antigen-stimulated dissociation of BCR mIg from Ig-alpha/Ig-beta: implications for receptor desensitization. Immunity (1999) 1.10
Rearrangement of lambda light chain genes in mature B cells in vitro and in vivo. Function of reexpressed recombination-activating gene (RAG) products. J Exp Med (1998) 1.07
Distinct signal thresholds for the unique antigen receptor-linked gene expression programs in mature and immature B cells. J Exp Med (1999) 1.06
Induction of tolerance in arthritogenic B cells with receptors of differing affinity for self-antigen. Proc Natl Acad Sci U S A (2006) 1.05
B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice. J Immunol (2004) 1.05
Ras activation of Erk restores impaired tonic BCR signaling and rescues immature B cell differentiation. J Exp Med (2010) 1.05
S1P3 confers differential S1P-induced migration by autoreactive and non-autoreactive immature B cells and is required for normal B-cell development. Eur J Immunol (2010) 1.04
An in depth analysis of the concept of "polyspecificity" assumed to characterize TCR/BCR recognition. Immunol Res (2008) 1.04
B cell receptor expression level determines the fate of developing B lymphocytes: receptor editing versus selection. Proc Natl Acad Sci U S A (2000) 1.04
Expression of recombination activating genes in germinal center B cells: involvement of interleukin 7 (IL-7) and the IL-7 receptor. J Exp Med (1998) 1.02
Germline V-genes sculpt the binding site of a family of antibodies neutralizing human cytomegalovirus. EMBO J (2008) 1.02
Different sensitivity to receptor editing of B cells from mice hemizygous or homozygous for targeted Ig transgenes. Proc Natl Acad Sci U S A (2000) 1.01
B cell receptor editing in tolerance and autoimmunity. Ann N Y Acad Sci (2011) 1.01
Secondary rearrangements and hypermutation generate sufficient B cell diversity to mount protective antiviral immunoglobulin responses. J Exp Med (1999) 0.97
Autoreactivity in HIV-1 broadly neutralizing antibodies: implications for their function and induction by vaccination. Curr Opin HIV AIDS (2014) 0.95
Innate pathways to B-cell activation and tolerance. Ann N Y Acad Sci (2010) 0.95
Positive selection of B cells expressing low densities of self-reactive BCRs. J Exp Med (2004) 0.92
Self-reactive B cells are not eliminated or inactivated by autoantigen expressed on thyroid epithelial cells. J Exp Med (1997) 0.91
The cellular location of self-antigen determines the positive and negative selection of autoreactive B cells. J Exp Med (2003) 0.89
Efficient generation of B lymphocytes by recognition of self-antigens. Eur J Immunol (2011) 0.87
Ontogeny of recognition specificity and functionality for the broadly neutralizing anti-HIV antibody 4E10. PLoS Pathog (2014) 0.85
The integration hypothesis: an evolutionary pathway to benign SIV infection. PLoS Pathog (2006) 0.84
Long-term control of alloreactive B cell responses by the suppression of T cell help. J Immunol (2008) 0.83
Global analysis of B cell selection using an immunoglobulin light chain-mediated model of autoreactivity. J Exp Med (2012) 0.83
Immature B lymphocytes from adult bone marrow exhibit a selective defect in induced hyperexpression of major histocompatibility complex class II and fail to show B7.2 induction. Immunology (2000) 0.82
The regulation of autoreactive B cells during innate immune responses. Immunol Res (2008) 0.80
Recombination activating genes (RAG) induce secondary Ig gene rearrangement in and subsequent apoptosis of human peripheral blood circulating B lymphocytes. Clin Exp Immunol (2004) 0.78
Anti-DNA IgA autoantibodies are spontaneously generated in mouse Peyer's patches. Immunology (1998) 0.77
B cell clonal elimination induced by membrane-bound self-antigen may require repeated antigen encounter or cell competition. Eur J Immunol (2000) 0.76
Human Ig knockin mice to study the development and regulation of HIV-1 broadly neutralizing antibodies. Immunol Rev (2017) 0.76
Censoring of self-reactive B cells by follicular dendritic cell-displayed self-antigen. J Immunol (2013) 0.76
Targeting Anti-Insulin B Cell Receptors Improves Receptor Editing in Type 1 Diabetes-Prone Mice. J Immunol (2015) 0.75
A better cell line for making hybridomas secreting specific antibodies. Nature (1978) 15.13
The V(D)J recombination activating gene, RAG-1. Cell (1989) 9.79
Clonal selection and learning in the antibody system. Nature (1996) 9.58
RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science (1990) 9.33
Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature (1988) 9.17
Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J Immunol (1980) 8.56
Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. Science (1990) 8.17
Variability in the lambda light chain sequences of mouse antibody. Nature (1970) 5.71
Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med (1993) 5.49
Receptor editing in self-reactive bone marrow B cells. J Exp Med (1993) 5.49
Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature (1989) 5.48
T-cell-receptor affinity and thymocyte positive selection. Nature (1996) 4.96
B220: a B cell-specific member of th T200 glycoprotein family. Nature (1981) 4.65
Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature (1994) 4.36
Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system. J Immunol Methods (1991) 4.34
Cellular mechanisms of immunologic tolerance. Annu Rev Immunol (1983) 4.07
Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature (1991) 4.04
Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature (1991) 3.32
The influence of antigen organization on B cell responsiveness. Science (1993) 3.32
Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell (1993) 3.09
Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice. Genes Dev (1994) 3.00
Antigen-induced B-cell death and elimination during germinal-centre immune responses. Nature (1995) 2.95
Cooperative interaction of B lymphocytes with antigen-specific helper T lymphocytes is MHC restricted. Nature (1981) 2.85
B lymphocytes may escape tolerance by revising their antigen receptors. J Exp Med (1993) 2.78
Soluble antigen can cause enhanced apoptosis of germinal-centre B cells. Nature (1995) 2.65
Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate. Immunity (1995) 2.55
Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature (1992) 2.52
Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu Rev Immunol (1994) 2.45
Peripheral deletion of self-reactive B cells. Nature (1991) 2.34
Allotypic specificities of murine IgD and IgM recognized by monoclonal antibodies. J Immunol (1984) 2.16
Reduced life span of anergic self-reactive B cells in a double-transgenic model. J Exp Med (1994) 2.15
The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J Exp Med (1996) 1.96
Light chain replacement: a new model for antibody gene rearrangement. J Exp Med (1995) 1.90
The site and stage of anti-DNA B-cell deletion. Nature (1995) 1.87
Empty and peptide-containing conformers of class I major histocompatibility complex molecules expressed in Drosophila melanogaster cells. Proc Natl Acad Sci U S A (1992) 1.79
Monoclonal antibodies specific for murine IgM I. Characterization of antigenic determinants on the four constant domains of the mu heavy chain. Eur J Immunol (1984) 1.58
Clonal deletion of autospecific B lymphocytes. Immunol Rev (1991) 1.42
Monoclonal anti-allotype antibody towards BALB/c IgM. Analysis of specificity and site of a V-C crossover in recombinant strain BALB-Igh-Va/Igh-Cb. Eur J Immunol (1987) 1.37
Analysis of cell-adhesion molecule interactions using surface plasmon resonance. Curr Opin Immunol (1996) 1.36
Positive and negative selection events during B lymphopoiesis. Curr Opin Immunol (1995) 1.31
Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40. J Immunol (1994) 1.30
The effect of mutations in the MHC class I peptide binding groove on the cytotoxic T lymphocyte recognition of the Kb-restricted ovalbumin determinant. Eur J Immunol (1990) 1.30
Light chain editing in kappa-deficient animals: a potential mechanism of B cell tolerance. J Exp Med (1994) 1.29
The binding of monoclonal antibodies to cell-surface molecules. A quantitative analysis with immunoglobulin G against two alloantigenic determinants of the human transplantation antigen HLA-A2. Biochem J (1983) 1.28
Analysis of macromolecular interactions using immobilized ligands. Anal Biochem (1992) 1.27
The bcl-2 gene product inhibits clonal deletion of self-reactive B lymphocytes in the periphery but not in the bone marrow. J Exp Med (1993) 1.17
Tolerance susceptibility of newly generating memory B cells. J Immunol (1991) 1.17
The definition of ABO factors in transplantation: relation to other humoral antibody states. Transplant Proc (1987) 1.13
Tolerance as an active process. Nature (1980) 1.10
Tolerance sensitivity of immature-stage B cells: can developmentally regulated B cell antigen receptor (BCR) signal transduction play a role? J Immunol (1996) 1.09
Cross-linking of membrane immunoglobulin D, in the absence of T cell help, kills mature B cells in vivo. J Exp Med (1995) 1.07
Biophysical studies of T-cell receptors and their ligands. Curr Opin Immunol (1996) 1.07
Alloantibodies can discriminate class I major histocompatibility complex molecules associated with various endogenous peptides. Proc Natl Acad Sci U S A (1993) 0.95
Censoring of self-reactive B cells with a range of receptor affinities in transgenic mice expressing heavy chains for a lysozyme-specific antibody. Int Immunol (1994) 0.95
Antigen-receptor cross-linking induces peritoneal B-cell apoptosis in normal but not autoimmunity-prone mice. Curr Biol (1994) 0.92
The affinity threshold for antigenic triggering differs for tolerance susceptible immature precursors vs mature primary B cells. J Immunol (1986) 0.85
Antigens as immunoregulators. Immunol Rev (1990) 0.84
T cell antigen receptor immune complexes demonstrating biologic and proteolytic activity. Int Immunol (1993) 0.82
Serological analysis of H-2 mutations using monoclonal antibodies. J Immunogenet (1985) 0.81
An alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science (1996) 5.93
Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nat Med (2001) 5.74
Receptor editing in self-reactive bone marrow B cells. J Exp Med (1993) 5.49
Cephamycins, a new family of beta-lactam antibiotics. I. Production by actinomycetes, including Streptomyces lactamdurans sp. n. Antimicrob Agents Chemother (1972) 5.23
Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1997) 4.93
Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties. J Antibiot (Tokyo) (1979) 4.82
Mutants of yeast defective in iso-1-cytochrome c. Genetics (1974) 4.73
Short cytoplasmic sequences serve as retention signals for transmembrane proteins in the endoplasmic reticulum. Cell (1989) 4.47
In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J Exp Med (2000) 4.37
Phosphonomycin, a new antibiotic produced by strains of streptomyces. Science (1969) 3.89
Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science (1998) 3.64
A deletion map of cyc1 mutants and its correspondence to mutationally altered iso-1-cytochromes c of yeast. Genetics (1975) 3.48
Contribution of receptor editing to the antibody repertoire. Science (2001) 3.45
Intracellular transport of class II MHC molecules directed by invariant chain. Nature (1990) 3.35
CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature (1996) 3.08
Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol (2001) 3.06
Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice. Genes Dev (1994) 3.00
Social deprivation and prognostic benefits of cardiac surgery: observational study of 44 902 patients from five hospitals over 10 years. BMJ (2009) 2.95
Mapping and gene conversion studies with the structural gene for iso-1-cytochrome C in yeast. Genetics (1975) 2.65
Identification and mutational relocation of the AUG codon initiating translation of iso-1-cytochrome c in yeast. J Biol Chem (1971) 2.57
Structural basis of T cell recognition. Annu Rev Immunol (1999) 2.45
Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes. Immunity (1994) 2.39
Receptor editing in a transgenic mouse model: site, efficiency, and role in B cell tolerance and antibody diversification. Immunity (1997) 2.35
Peripheral deletion of self-reactive B cells. Nature (1991) 2.34
V(D)J recombination in mature B cells: a mechanism for altering antibody responses. Science (1997) 2.21
Results of balloon pulmonary valvuloplasty as a palliative procedure in tetralogy of Fallot. J Am Coll Cardiol (1991) 2.10
High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. Proc Natl Acad Sci U S A (1994) 2.09
Cardiac arrest during intramedullary nailing for femoral metastases. J Bone Joint Surg Br (1993) 2.07
Acute pain after thoracic surgery predicts long-term post-thoracotomy pain. Clin J Pain (1996) 2.05
Neuroaxial blockade and psoriasis. Int J Obstet Anesth (2007) 2.03
RCPE UK consensus statement on diabetes. J R Coll Physicians Edinb (2010) 2.03
Receptor editing occurs frequently during normal B cell development. J Exp Med (1998) 2.01
V(D)J recombinase induction in splenic B lymphocytes is inhibited by antigen-receptor signalling. Nature (1998) 1.97
Organization and expression of non-Alu family interspersed repetitive DNA sequences in the mouse genome. J Mol Biol (1984) 1.96
Cell wall core galactofuran synthesis is essential for growth of mycobacteria. J Bacteriol (2001) 1.90
T cells can use either T cell receptor or CD28 receptors to absorb and internalize cell surface molecules derived from antigen-presenting cells. J Exp Med (2000) 1.88
Cellular response to modulated radiation fields. Phys Med Biol (2007) 1.88
Tiacumicins, a novel complex of 18-membered macrolide antibiotics. I. Taxonomy, fermentation and antibacterial activity. J Antibiot (Tokyo) (1987) 1.87
Efficacy of D0870 compared with those of itraconazole and amphotericin B in two murine models of invasive aspergillosis. Antimicrob Agents Chemother (1995) 1.86
The mouse CD1d-restricted repertoire is dominated by a few autoreactive T cell receptor families. J Exp Med (2001) 1.85
A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. Science (2000) 1.84
Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues. J Histochem Cytochem (1998) 1.80
Alanine scanning mutagenesis of an alphabeta T cell receptor: mapping the energy of antigen recognition. Immunity (1998) 1.80
A role for acidic residues in di-leucine motif-based targeting to the endocytic pathway. J Biol Chem (1995) 1.78
Developmental regulation of B lymphocyte immune tolerance compartmentalizes clonal selection from receptor selection. Cell (1998) 1.78
BCR ligation induces receptor editing in IgM+IgD- bone marrow B cells in vitro. Immunity (1997) 1.76
A redrawn Vandenberg and Kuse mental rotations test: different versions and factors that affect performance. Brain Cogn (1995) 1.71
Requirements for peptide-induced T cell receptor downregulation on naive CD8+ T cells. J Exp Med (1997) 1.70
Alphabeta T cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization. Proc Natl Acad Sci U S A (1997) 1.67
Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues. Immunity (1998) 1.67
Demonstration of the UAA ochre codon in bakers yeast by amino-acid replacements in iso-1-cytochrome c. J Mol Biol (1972) 1.66
Role of chain pairing for the production of functional soluble IA major histocompatibility complex class II molecules. J Exp Med (1996) 1.66
Determinants of chemotactic signal amplification in Escherichia coli. J Mol Biol (2001) 1.64
Liver transplantation as a treatment for familial amyloidotic polyneuropathy. Ann Intern Med (1994) 1.63
Arithmetic skills in patients with unilateral cerebral lesions. Cortex (1986) 1.63
Age is not an impediment to effective use of patient-controlled analgesia by surgical patients. Anesthesiology (2000) 1.62
Tyrosine substitutions resulting from suppression of amber mutants of iso-1-cytochrome c in yeast. J Mol Biol (1973) 1.59
Tau, ubiquitin, and alpha B-crystallin immunohistochemistry define the principal causes of degenerative frontotemporal dementia. Arch Neurol (1995) 1.59
Congenital testicular maldescent: significance of the complete hernial sac. Br J Urol (1995) 1.56
A functional hot spot for antigen recognition in a superagonist TCR/MHC complex. Immunity (2000) 1.54
Recombinant TGF-beta 1 is synthesized as a two-component latent complex that shares some structural features with the native platelet latent TGF-beta 1 complex. Growth Factors (1989) 1.51
Ethyl-substituted erythromycin derivatives produced by directed metabolic engineering. Proc Natl Acad Sci U S A (1998) 1.50
A population of murine gammadelta T cells that recognize an inducible MHC class Ib molecule. Science (2000) 1.49
Reducing the risk of retained throat packs after surgery. Br J Oral Maxillofac Surg (2012) 1.48
Epidermal cancer associated with expression of human papillomavirus type 16 E6 and E7 oncogenes in the skin of transgenic mice. Proc Natl Acad Sci U S A (1993) 1.48
Antigens varying in affinity for the B cell receptor induce differential B lymphocyte responses. J Exp Med (1998) 1.47
Peptide antagonism and T cell receptor interactions with peptide-MHC complexes. Immunity (1998) 1.46
Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial. Blood (1992) 1.45
Structural basis of 2C TCR allorecognition of H-2Ld peptide complexes. Immunity (1998) 1.45
Acyltransferase domain substitutions in erythromycin polyketide synthase yield novel erythromycin derivatives. J Bacteriol (1997) 1.42
Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells. J Exp Med (1997) 1.41
Reduced free radical activity detected by decreased diene conjugates in insulin-dependent diabetic patients. Diabet Med (1988) 1.40
Management preferences following radical inguinal orchidectomy for Stage I testicular seminoma in Australasia. Australas Radiol (2002) 1.40
Cerebral arterial narrowing with nicotine patch. Lancet (1993) 1.40
The reality of treating dyslipidaemia in patients with coronary heart disease: a primary care survey. Int J Clin Pract (2003) 1.40
Current imaging of childhood urinary infections: prospective survey. BMJ (1992) 1.39
T-cell recognition of the 18-kilodalton antigen of Mycobacterium leprae. Infect Immun (1989) 1.39
Selection of functional T cell receptor mutants from a yeast surface-display library. Proc Natl Acad Sci U S A (1999) 1.38
Altered antigen presentation in mice lacking H2-O. Immunity (1998) 1.36
The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder. J Immunol (2000) 1.36
An erythromycin analog produced by reprogramming of polyketide synthesis. Proc Natl Acad Sci U S A (1993) 1.35
Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia. Gene Ther (2006) 1.35
Self-antigen does not accelerate immature B cell apoptosis, but stimulates receptor editing as a consequence of developmental arrest. Proc Natl Acad Sci U S A (1997) 1.33
Differences in antigen recognition and cytolytic activity of CD8(+) and CD8(-) T cells that express the same antigen-specific receptor. Proc Natl Acad Sci U S A (2001) 1.30
Methods for a prompt and reliable laboratory diagnosis of Pompe disease: report from an international consensus meeting. Mol Genet Metab (2007) 1.29
Modulation of the neuronal glutamate transporter EAAC1 by the interacting protein GTRAP3-18. Nature (2001) 1.29
Acoustic modeling of American English /r/. J Acoust Soc Am (2000) 1.28
A novel HLA class II molecule (DR alpha-DQ beta) created by mismatched isotype pairing. Nature (1987) 1.26
Curvature and tortuosity of the superficial femoral artery: a possible risk factor for peripheral arterial disease. J Appl Physiol (1985) (2006) 1.26
In situ characterization of beta-amyloid in Alzheimer's diseased tissue by synchrotron Fourier transform infrared microspectroscopy. Biophys J (1996) 1.25
Transfected Drosophila cells as a probe for defining the minimal requirements for stimulating unprimed CD8+ T cells. Proc Natl Acad Sci U S A (1996) 1.25